Dual-Shaped Silver Nanoparticle Labels for Electrochemical Detection of Bioassays
Source abstract
Abstract
In this paper we demonstrate the use of dual-shaped silver nanoparticles (AgNPs) as detection labels for electrochemical bioassays. The key finding is that by using AgNP labels having two different shapes simultaneously, the limit of detection (LOD) for the assays is lowered compared to using either of the two shapes separately. The two shapes were silver nanocubes (AgNCs) having edge lengths of 40 ± 4 nm and spherical AgNPs (sAgNPs) having diameters of 20 ± 3 nm. Two different bioassays were examined. In both cases the Ag labels were functionalized with antibodies. In the one assay, the labels are directly linked to a second antibody immobilized on magnetic beads. In the second assay, the antibodies on the AgNP labels and the antibodies on the magnetic beads are linked via a peptide. The peptide is N-terminal prohormone brain natriuretic peptide (NT-proBNP), which is a heart failure marker. The efficacy of the two electrochemical assays as a function of the ratio of the two labels was investigated using a galvanic exchange/anodic stripping voltammetry method. The key finding is that by optimizing the ratio of the two types of AgNP labels, it is possible to decrease the LOD of the assays without compromising the dynamic range compared to using either of the two labels independently. This made it possible to achieve the clinically relevant range for NT-proBNP analysis used by physicians for heart failure risk stratification.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrochemical Analysis and Applications · Advanced biosensing and bioanalysis techniques · Molecular Junctions and Nanostructures
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, The University of Texas at Austin, 100 E. 24th Street, Stop A1590, Austin, Texas 78712-1224, United States
Funding
Welch Foundation · National Heart, Lung, and Blood Institute
References (46)
Show source-provided references
1. 10.1021/acs.langmuir.8b0332510.1021/acs.langmuir.8b03325 ↗
2. 10.1016/j.jacc.2016.09.93110.1016/j.jacc.2016.09.931 ↗
3. 10.1016/j.jchf.2014.05.00710.1016/j.jchf.2014.05.007 ↗
4. 10.1373/clinchem.2006.06957510.1373/clinchem.2006.069575 ↗
5. 10.1161/circulationaha.112.12048510.1161/circulationaha.112.120485 ↗
6. 10.1021/acssensors.0c0016710.1021/acssensors.0c00167 ↗
7. 10.1016/s0956-5663(03)00084-810.1016/s0956-5663(03)00084-8 ↗
8. 10.1149/2.106204jes10.1149/2.106204jes ↗
9. 10.1021/es502320210.1021/es5023202 ↗
10. Hasan S. · Res. J. Recent Sci. · 2014 · 4 · 1
11. 10.1088/0957-4484/16/6/01610.1088/0957-4484/16/6/016 ↗
12. 10.1016/j.cej.2006.03.00310.1016/j.cej.2006.03.003 ↗
13. 10.1021/la052797j10.1021/la052797j ↗
14. 10.1109/jtehm.2017.274092010.1109/jtehm.2017.2740920 ↗
15. 10.1021/acs.jpcc.5b1200410.1021/acs.jpcc.5b12004 ↗
16. 10.1021/bc300481510.1021/bc3004815 ↗
17. 10.1117/1.357915710.1117/1.3579157 ↗
18. 10.1016/j.snb.2016.04.15910.1016/j.snb.2016.04.159 ↗
19. 10.1016/j.jsamd.2018.03.00310.1016/j.jsamd.2018.03.003 ↗
20. 10.1002/elan.20030293010.1002/elan.200302930 ↗
21. 10.1039/c5lc00731c10.1039/c5lc00731c ↗
22. 10.1039/c5an02386f10.1039/c5an02386f ↗
23. 10.1039/c0lc00204f10.1039/c0lc00204f ↗
24. 10.1177/104063871558833010.1177/1040638715588330 ↗
25. 10.1016/j.sbsr.2016.08.00110.1016/j.sbsr.2016.08.001 ↗
26. 10.1073/pnas.68.8.190210.1073/pnas.68.8.1902 ↗
27. 10.1021/ac901838910.1021/ac9018389 ↗
28. 10.1021/ja711298b10.1021/ja711298b ↗
29. 10.1177/40.2.155216210.1177/40.2.1552162 ↗
30. 10.1088/2053-1591/abd13910.1088/2053-1591/abd139 ↗
31. 10.1016/j.ab.2020.11397510.1016/j.ab.2020.113975 ↗
32. 10.1039/b806051g10.1039/b806051g ↗
33. 10.1021/acssensors.5b0005110.1021/acssensors.5b00051 ↗
34. Bard A. J. · 2001
35. 10.1126/science.121282210.1126/science.1212822 ↗
36. 10.1557/mrs2005.9810.1557/mrs2005.98 ↗
37. 10.1021/acssensors.0c0237710.1021/acssensors.0c02377 ↗
38. 10.1021/bi060704710.1021/bi0607047 ↗
39. 10.1038/nprot.2007.32610.1038/nprot.2007.326 ↗
40. 10.1002/adma.20080025510.1002/adma.200800255 ↗
41. 10.1021/nl070838l10.1021/nl070838l ↗
42. 10.1021/nl025531v10.1021/nl025531v ↗
43. 10.1021/ja066023g10.1021/ja066023g ↗
44. 10.1021/acs.bioconjchem.9b0073710.1021/acs.bioconjchem.9b00737 ↗
45. Thermo Fisher. Dynabeads MyOne Streptavidin T1 Protocol; 2016.
46. Bio-Rad Laboratories. LYNX Rapid Plus Biotin (Type 2) Antibody Conjugation Kit Protocol, 2011, 2–4.